Our Team
Dr Zuhayr Adia, MBBS BSc(Hons)
Founder, Managing Director
Dr Adia graduated from King’s College London and trained at some of the countries leading hospitals including Guy’s Hospital, St Thomas’ Hospital, and King’s College Hospitals. His special interests include Psychiatry, Cannabinoid Pharmacology, Pain Management and Healthcare Management.
Dr Adia’s interest in Cannabinoid Pharmacology and Pain Management arose from his personal experience of living with a highly invasive nerve tumour and severe chronic pain, searching for relief when all other conventional medical treatments had failed.
Professor Ebrahim Adia, PhD
Senior Advisor
Professor Adia currently serve as Pro Vice-Chancellor (Business Development and Partnerships) at the University of Central Lancashire (UCLan).
He is also Chair of Lancashire Teaching Hospitals, a regional specialist centre for cancer, major trauma, disablement services, neurosurgery and neurology, renal and vascular for 1.5 million people.
Having served as Acting Leader and Deputy Leader of Bolton Council, Deputy Portfolio Holder for Economic Strategy at the Greater Manchester Combined Authority Director at the Growth Company, Vice-Chair of the Bolton NHS Primary Care Trust, Board member of the University of Central Lancashire (UCLan) for eight years and as an Independent Expert Adviser to the Audit Commission Dr Adia is experienced in the management of large public and private organisations, particularly within healthcare and academia.
Dr Samir Naseef, MD
Medical Advisor
Dr Naseef is a Head GP, with over 20 years of experience in practising medicine, having trained at world class hospitals.
Dr Naseef has also has demonstrable experience in the managing of private healthcare organisations, ensuring the maintenance of high quality care and raising standards in any organisation he is part of. As such, his expertise is invaluable to Neuraleaf, whether it is in understanding the needs of patients with chronic conditions, or ensuring our products meet the high standards demanded by British medical professionals.
Dr Naseef has witnessed first hand the ability of high quality, clinically safe and pharmaceutically pure CBD like Neuraleaf to improve the quality of life of patients who have not responded adequately to standard treatment regimens.
His expert guidance ensures Neuraleaf remains firm on its promise to improve the lives of patients, through research, development, education, and scientific & clinical excellence.
Mr Jonathan Garrett,
Director of Finance and Accounting
Jonathan is a Senior Accountant specialising in Audit and Accounts at multi award winning accounting firm – KJG.
His experience includes giving expert advice in taxation, corporate finance, audit, accounts, payroll and insolvency.
Having worked with businesses turning over up to £100 million, Jonathan brings his expertise to Neuraleaf to ensure that Neuraleaf operated at maximal financial efficiency.